How many drugs treat Dilated pupil?

Drug Landscape tracks 5 marketed treatments for Dilated pupil (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/dilated-pupil.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Dilated pupil — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dilated pupil (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Dilated pupil, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Sudafed PE	phenylephrine	Generic (multiple manufacturers)	Alpha-1 adrenergic agonist (decongestant/vasopressor)	Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor	1976-01-01
Cyclogyl	CYCLOPENTOLATE	Alcon Labs Inc	cyclopentolate	Muscarinic acetylcholine receptor M3	1974-01-01
Paremyd	hydroxyamfetamine	Pharmics	Adrenergic Receptor Agonist	Trace amine-associated receptor 1	1969-01-01
Phenergan Vc W/ Codeine	PHENYLEPHRINE BITARTRATE	ANI Pharmaceuticals	Nonsteroidal Anti-inflammatory Drug [EPC]	Alpha-1B adrenergic receptor	1952-01-01
scopolamin	scopolamin	University Hospital, Angers		Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

ANI Pharmaceuticals · 1 drug in Dilated pupil
Alcon Labs Inc · 1 drug in Dilated pupil
Generic (multiple manufacturers) · 1 drug in Dilated pupil
Pharmics · 1 drug in Dilated pupil
University Hospital, Angers · 1 drug in Dilated pupil

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Dilated pupil:

Cite this brief

Drug Landscape (2026). Dilated pupil — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/dilated-pupil. Accessed 2026-06-10.

Dilated pupil full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing